About this event
This webinar aims to outline the importance and diagnostic specificity of CDT (Carbohydrate-Deficient Transferrin) as a marker of chronic alcohol abuse, particularly in the context of forensic settings.
The strong analytical performance of CDT will notably be exposed, with a specific focus on its association with the risk of road traffic accidents under alcohol abuse.
Bachelor's degree in Biological Sciences, Master's degree, and PhD in Forensic Science.
Following various study and work experiences abroad in the field of forensic sciences, Dr. Porpiglia has been working for six years as a research fellow at the Forensic Toxicology laboratories of the Institute of Forensic Medicine in Verona, where she has expanded her knowledge and use of analytical techniques in this field, including capillary electrophoresis, HPLC and mass spectrometry. In particular, in recent years Dr. Porpiglia has gained experience in chronic alcohol abuse with a focus on CDT.
Dr. Porpiglia has published book chapters and scientific articles related to forensic toxicology and contributed to national and international conferences. Among others, she is the first author of papers emphasizing the analytical and clinical interest of CDT for chronic alcohol abuse and its importance in the context of road traffic accident risk predictivity.
Dr. Porpiglia is a member of the Italian Group of Forensic Toxicologists (GTFI) and collaborates with the Working Group for CDT (WG-CDT) established by the IFCC (International Federation of Clinical Chemistry and Laboratory Medicine).
Sebia is the world’s leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing.